Defunct Company
Total Trials
61
As Lead Sponsor
58
As Collaborator
3
Total Enrollment
25,227
NCT00073021
Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative Colitis
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 30, 2000
Completion: Sep 30, 2003
NCT00577473
Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)
Start: Feb 28, 2001
Completion: Feb 28, 2003
NCT01249261
Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover
Start: Oct 31, 2001
Completion: May 31, 2003
NCT00331123
Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido
Start: May 31, 2002
Completion: Jul 31, 2006
NCT00331214
Start: Jun 30, 2002
NCT00338312
Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
NCT00349791
Study to Assess the Efficacy/Safety of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido
Completion: Oct 31, 2003
NCT00619957
Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis
Completion: May 31, 2007
NCT00577850
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Phase: Phase 1
Start: Nov 30, 2002
Completion: Feb 29, 2004
NCT01070979
Hormone Replacement Therapy for Use in Postmenopausal Women for Relief of Hot Flushes and Urogenital Symptoms.
Start: Feb 28, 2003
NCT00837746
Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
Phase: N/A
Start: Apr 30, 2003
Completion: Oct 31, 2006
NCT00577421
Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO
Start: Jun 30, 2003
Completion: Jan 31, 2006
NCT00778154
Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate
Start: Jan 31, 2004
Completion: Dec 31, 2006
NCT00932321
Study of Safety and Efficacy of an Oral Contraceptive
Completion: Nov 30, 2004
NCT00577837
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
Phase: Phase 2
Start: Apr 30, 2004
Completion: Jun 30, 2005
NCT00131495
Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
Start: Jul 31, 2004
Completion: Feb 28, 2007
NCT00106028
Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children
Start: Nov 30, 2004
Completion: Mar 31, 2010
NCT00247273
A Study of Monthly Risedronate for Osteoporosis
Start: Oct 31, 2005
Completion: Apr 30, 2008
NCT00254618
A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
Completion: Jun 30, 2008
NCT00386360
Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method
Start: Apr 30, 2006
Completion: Sep 30, 2009
NCT00338052
Study of Bleeding With Extended Administration of an Oral Contraceptive
Start: Jun 30, 2006
NCT00350415
A Double Blind Study for the Treatment of Acute Ulcerative Colitis
NCT00577720
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
Start: Jul 31, 2006
Completion: Jan 31, 2007
NCT00384046
Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen
Start: Nov 30, 2006
Completion: Jul 31, 2007
NCT00391807
Completion: Sep 30, 2008
NCT00512499
Strategies to Treat Osteoporosis Following a Fragility Fracture
Role: Collaborator
Start: Feb 28, 2007
Completion: Jul 31, 2016
NCT00751699
Pharmacokinetics of Asacol 2.4 g/Day and Lialda 2.4 g/Day in Healthy Volunteers
Start: Mar 31, 2007
Completion: Apr 30, 2007
NCT00467259
Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women
Start: Apr 30, 2007
Completion: Jan 31, 2009
NCT00477633
Start: Jun 30, 2007
Completion: Feb 28, 2009
NCT00475189
"Study of Loestrin 24(24 Days of Real Pills) Fe Versus Loestrin 1/20 (21 Real Pills)"
Completion: Nov 30, 2008
NCT00505778
A Comparison of Once a Day Dose Compared to 2 Doses/Day
Start: Jul 31, 2007
Completion: Jul 31, 2009
NCT00791856
Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
Completion: May 31, 2008
NCT00780507
Fecal Biomarker Study for Patients With Ulcerative Colitis
Start: Aug 31, 2007
NCT00541658
A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
Start: Oct 31, 2007
Completion: Apr 30, 2010
NCT00554099
Asacol Acute Diverticulitis(DIVA)Study
Start: Nov 30, 2007
NCT00755872
Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate
Completion: Feb 29, 2008
NCT00699777
Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects
Start: Jan 31, 2008
NCT00612573
Treatment of Moderate to Severe Facial Acne Vulgaris
Start: Feb 29, 2008
Completion: Dec 31, 2008
NCT00635609
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate
Phase: Phase 4
Start: Mar 31, 2008
NCT00577395
Bone Microarchitecture in Osteopenic Postmenopausal Women
Start: Jul 31, 2008
NCT00717145
Food Effects on the Relative Bioavailability of Different Dosages of Risedronate
NCT00712322
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
Start: Oct 7, 2008
Completion: May 23, 2013
NCT00713310
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative Colitis
Start: Dec 31, 2008
Completion: Mar 31, 2011
NCT00846196
A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects
Start: Jan 31, 2009
Completion: May 31, 2009
NCT00868907
Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food
Start: Mar 31, 2009
Completion: Apr 30, 2009
NCT00918749
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women
Start: May 31, 2009
Completion: Oct 31, 2009
NCT00957034
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure
Start: Jul 31, 2009
Completion: May 31, 2010
NCT01037218
Treatment of Erectile Dysfunction II
Start: Sep 30, 2009
NCT01037244
Treatment of Erectile Dysfunction I
NCT01004185
Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative Colitis
Start: Oct 31, 2009
NCT01065012
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Start: Jan 31, 2010
Completion: Feb 28, 2011
NCT01572766
Effect of Assessing Risk for Osteoporosis on Physician and Patient Behaviors
Start: Feb 28, 2010
NCT01113931
Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin
Start: Apr 30, 2010
Completion: Oct 31, 2010
NCT01230541
Effect of Udenafil on Spermatogenesis
Start: Sep 30, 2010
Completion: Nov 30, 2011
NCT01400776
Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women
Start: Jun 29, 2011
Completion: Feb 27, 2012
NCT01455597
Evaluate Long-Term Safety and Efficacy WC3011 (Estradiol Vaginal Cream)
Start: Oct 20, 2011
Completion: Dec 3, 2012
NCT01816139
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
Start: Jan 31, 2013
Completion: Nov 19, 2013
NCT01810575
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
Start: Feb 28, 2013
Completion: Apr 30, 2013
NCT01845649
Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia
Start: Apr 12, 2013
Completion: Nov 20, 2013
NCT01939184
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Start: Aug 31, 2013
Completion: Apr 30, 2014
NCT02670785
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Start: Feb 15, 2016
Completion: Nov 14, 2016